Bendamustine for the first-line treatment of chronic lymphocytic leukaemia

TA216 Leukaemia (lymphocytic) - bendamustine: review decision - March 2014 information  

Appendix A - Decision paper presented to the Institute's Guidance Executive ^{PDF 103 KB} 03 March 2014  

TA216 Leukaemia (lymphocytic) - bendamustine: review proposal - December 2013 information  

TA216 Leukaemia (lymphocytic) - bendamustine: Appendix A - provisional matrix of stakeholders ^{PDF 99.62 KB} 20 December 2013  

TA216 Leukaemia (lymphocytic) - bendamustine: Appendix B - proposal paper presented to the Institute's Guidance Executive ^{PDF 296.49 KB} 20 December 2013  

Leukaemia (lymphocytic) - bendamustine: equality impact assessment ^{PDF 19.56 KB} 23 February 2011  

Leukaemia (lymphocytic) - bendamustine: final appraisal determination information  

Leukaemia (lymphocytic) - bendamustine: final appraisal determination document ^{PDF 228.23 KB} 23 December 2010  

Leukaemia (lymphocytic) - bendamustine: pre-meeting briefing ^{PDF 252.32 KB} 23 December 2010  

Leukaemia (lymphocytic) - bendamustine: final scope and final matrix of comsultees and commentators  

Leukaemia (lymphocytic) - bendamustine: scope ^{PDF 45.94 KB} 23 December 2010  

Leukaemia (lymphocytic) - bendamustine: matrix ^{PDF 55.21 KB} 23 December 2010  

Leukaemia (lymphocytic) - bendamustine: manufacturer submission ^{PDF 3.18 MB} 23 December 2010  

Leukaemia (lymphocytic) - bendamustine: clarification letters  

Leukaemia (lymphocytic) - bendamustine: NICE request to the manufacturer for clarification on their submission ^{PDF 70.99 KB} 23 December 2010  

Leukaemia (lymphocytic) - bendamustine: manufacturer's response to NICE's request for clarification 1 ^{PDF 354.34 KB} 23 December 2010  

Leukaemia (lymphocytic) - bendamustine: manufacturer's response to NICE's request for clarification 2 ^{PDF 35.81 KB} 23 December 2010  

Leukaemia (lymphocytic) - bendamustine: patient group, professional group and NHS organisation submissions  

Leukaemia (lymphocytic) - bendamustine: British Society for Haematology and Royal College of Pathologists (joint submission) ^{PDF 223.02 KB} 23 December 2010  

Leukaemia (lymphocytic) - bendamustine: Chronic Lymphocytic Leukaemia Support Association ^{PDF 269.77 KB} 23 December 2010  

Leukaemia (lymphocytic) - bendamustine: Leukaemia CARE ^{PDF 33.71 KB} 23 December 2010  

Leukaemia (lymphocytic) - bendamustine: Lymphoma Association ^{PDF 173.23 KB} 23 December 2010  

Leukaemia (lymphocytic) - bendamustine: Royal College of Physicians / NCRI / RCR / ACP / JCCO ^{PDF 95.12 KB} 23 December 2010  

Leukaemia (lymphocytic) - bendamustine: United Kingdom Chronic Lymphocytic Leukaemia Forum ^{PDF 211.89 KB} 23 December 2010  

Leukaemia (lymphocytic) - bendamustine: Expert personal perspectives  

Leukaemia (lymphocytic) - bendamustine: Jane Barnard nominated ^{PDF 14.76 KB} 23 December 2010  

Leukaemia (lymphocytic) - bendamustine: Dr Chris Fegan ^{PDF 16.21 KB} 23 December 2010  

Leukaemia (lymphocytic) - bendamustine: Professor Andrew Pettitt ^{PDF 14.31 KB} 23 December 2010  

Leukaemia (lymphocytic) - bendamustine: Chonette Taylor ^{PDF 13.05 KB} 23 December 2010  

Leukaemia (lymphocytic) - bendamustine: Evidence Review Group report ^{PDF 1.63 MB} 23 December 2010  

Leukaemia (lymphocytic) - bendamustine: Evidence Review Group report - factual accuracy check ^{PDF 52.58 KB} 23 December 2010  

Leukaemia (lymphocytic) - bendamustine: response to consultee and commentator comments on the draft scope ^{PDF 86.8 KB} 07 July 2010  

Leukaemia (lymphocytic) - bendamustine: institutes response to consultee and commentator comments on the provisional matrix ^{PDF 22.37 KB} 02 July 2010  

Leukaemia (lymphocytic) - bendamustine: final matrix ^{PDF 31.38 KB} 02 July 2010  

Leukaemia (lymphocytic) - bendamustine: final scope ^{PDF 26.48 KB} 02 July 2010  

Appendix C - provisional matrix (pre-referral) - November 2009 ^{PDF 54.91 KB} 16 April 2010  

Appendix B - draft scope for consultation (pre-referral) - November 2009 ^{PDF 47.02 KB} 16 April 2010